Laliberté, François <br/><br/>
Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.  [electronic resource] 

 -  Clinical therapeutics  Mar 2015 
 - 554-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2015.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticoagulants--therapeutic use<br/>Atrial Fibrillation--complications<br/>Databases, Factual<br/>Female<br/>Health Resources--statistics & numerical data<br/>Hospitalization<br/>Humans<br/>Length of Stay--statistics & numerical data<br/>Male<br/>Middle Aged<br/>Propensity Score<br/>Retrospective Studies<br/>Rivaroxaban--therapeutic use<br/>Stroke--prevention & control<br/>Warfarin--therapeutic use